These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 34883205)

  • 1. Production and characterization of mono-PEGylated alpha-1 antitrypsin for augmentation therapy.
    Liu X; Vanvarenberg K; Kouassi KGW; Mahri S; Vanbever R
    Int J Pharm; 2022 Jan; 612():121355. PubMed ID: 34883205
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alpha-1 Antitrypsin Therapy in Cystic Fibrosis and the Lung Disease Associated with Alpha-1 Antitrypsin Deficiency.
    McElvaney NG
    Ann Am Thorac Soc; 2016 Apr; 13 Suppl 2():S191-6. PubMed ID: 27115956
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of the PEG length and PEGylation site on the structural, thermodynamic, thermal, and proteolytic stability of mono-PEGylated alpha-1 antitrypsin.
    Liu X; Kouassi KGW; Vanbever R; Dumoulin M
    Protein Sci; 2022 Sep; 31(9):e4392. PubMed ID: 36040264
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Strategies for aerosol therapy of alpha 1-antitrypsin deficiency by the aerosol route.
    Hubbard RC; Crystal RG
    Lung; 1990; 168 Suppl():565-78. PubMed ID: 2117165
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Delivery of Alpha-1 Antitrypsin to Airways.
    Griese M; Scheuch G
    Ann Am Thorac Soc; 2016 Aug; 13 Suppl 4():S346-51. PubMed ID: 27564672
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alpha-1 Antitrypsin Augmentation Inhibits Proteolysis of Neutrophil Membrane Voltage-Gated Proton Channel-1 in Alpha-1 Deficient Individuals.
    Hawkins P; Sya J; Hup NK; Murphy MP; McElvaney NG; Reeves EP
    Medicina (Kaunas); 2021 Aug; 57(8):. PubMed ID: 34441020
    [No Abstract]   [Full Text] [Related]  

  • 7. Alpha-1 antitrypsin augmentation therapy.
    Wewers MD; Crystal RG
    COPD; 2013 Mar; 10 Suppl 1():64-7. PubMed ID: 23527997
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Methods of Purification and Application Procedures of Alpha1 Antitrypsin: A Long-Lasting History.
    Viglio S; Iadarola P; D'Amato M; Stolk J
    Molecules; 2020 Sep; 25(17):. PubMed ID: 32887469
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-inflammatory and immunomodulatory properties of α1-antitrypsin without inhibition of elastase.
    Jonigk D; Al-Omari M; Maegel L; Müller M; Izykowski N; Hong J; Hong K; Kim SH; Dorsch M; Mahadeva R; Laenger F; Kreipe H; Braun A; Shahaf G; Lewis EC; Welte T; Dinarello CA; Janciauskiene S
    Proc Natl Acad Sci U S A; 2013 Sep; 110(37):15007-12. PubMed ID: 23975926
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gene Therapy for Alpha-1 Antitrypsin Deficiency Lung Disease.
    Chiuchiolo MJ; Crystal RG
    Ann Am Thorac Soc; 2016 Aug; 13 Suppl 4(Suppl 4):S352-69. PubMed ID: 27564673
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The BLT1 Inhibitory Function of α-1 Antitrypsin Augmentation Therapy Disrupts Leukotriene B4 Neutrophil Signaling.
    O'Dwyer CA; O'Brien ME; Wormald MR; White MM; Banville N; Hurley K; McCarthy C; McElvaney NG; Reeves EP
    J Immunol; 2015 Oct; 195(8):3628-41. PubMed ID: 26371243
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The efficacy and safety of inhaled human α-1 antitrypsin in people with α-1 antitrypsin deficiency-related emphysema.
    Franciosi AN; McCarthy C; McElvaney NG
    Expert Rev Respir Med; 2015 Apr; 9(2):143-51. PubMed ID: 25598013
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aralast: an alpha 1-protease inhibitor for the treatment of alpha-antitrypsin deficiency.
    Mordwinkin NM; Louie SG
    Expert Opin Pharmacother; 2007 Oct; 8(15):2609-14. PubMed ID: 17931094
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protease-Specific Biomarkers to Analyse Protease Inhibitors for Emphysema Associated with Alpha 1-Antitrypsin Deficiency. An Overview of Current Approaches.
    Viglio S; Bak EG; Schouten IGM; Iadarola P; Stolk J
    Int J Mol Sci; 2021 Jan; 22(3):. PubMed ID: 33494436
    [TBL] [Abstract][Full Text] [Related]  

  • 15. α
    Murphy MP; McEnery T; McQuillan K; McElvaney OF; McElvaney OJ; Landers S; Coleman O; Bussayajirapong A; Hawkins P; Henry M; Meleady P; Reeves EP; McElvaney NG
    Eur Respir J; 2020 Apr; 55(4):. PubMed ID: 32060059
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Biological Effects of Double-Dose Alpha-1 Antitrypsin Augmentation Therapy. A Pilot Clinical Trial.
    Campos MA; Geraghty P; Holt G; Mendes E; Newby PR; Ma S; Luna-Diaz LV; Turino GM; Stockley RA
    Am J Respir Crit Care Med; 2019 Aug; 200(3):318-326. PubMed ID: 30965011
    [No Abstract]   [Full Text] [Related]  

  • 17. Long-term clinical outcomes following treatment with alpha 1-proteinase inhibitor for COPD associated with alpha-1 antitrypsin deficiency: a look at the evidence.
    Rahaghi FF; Miravitlles M
    Respir Res; 2017 May; 18(1):105. PubMed ID: 28558837
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oxidation-resistant and thermostable forms of alpha-1 antitrypsin from
    Zhu W; Li L; Deng M; Wang B; Li M; Ding G; Yang Z; Medynski D; Lin X; Ouyang Y; Lin J; Li L; Lin X
    FEBS Open Bio; 2018 Oct; 8(10):1711-1721. PubMed ID: 30338221
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alpha-1 Antitrypsin Therapy Modifies Neutrophil Adhesion in Patients with Obstructive Lung Disease.
    McEnery T; White MM; Gogoi D; Coleman O; Bergin D; Jundi B; Flannery R; Alsaif FAT; Landers SA; Casey M; Dunlea D; Meleady P; McElvaney NG; Reeves EP
    Am J Respir Cell Mol Biol; 2022 Jul; 67(1):76-88. PubMed ID: 35507773
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alpha-1 antitrypsin (AAT) deficiency - what are the treatment options?
    Modrykamien A; Stoller JK
    Expert Opin Pharmacother; 2009 Nov; 10(16):2653-61. PubMed ID: 19827990
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.